UPC APP 17607/2025

—·EP4183412: RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

Case details: Status
—
Action
Procedural application
Category
Withdrawal Applications
Parties: Claimants
Pfizer, Inc.
Pfizer Europe MA EEIG
Pfizer B.V.
Pfizer S.A.
Pfizer Manufacturing Belgium NV
Pfizer Service Company S.R.L.
Pfizer Pharma GmbH
Pfizer Limited
Reps: Gareth Williams
Respondents
GlaxoSmithKline Biologicals SA
Reps: Oliver Jan Juengst; Daniela Kinkeldey
Division: Milan CD
Judges: Andrea Postiglione · Presiding Judge
Anna-Lena Klein · Judge-rapporteur
Steen Wadskov-Hansen · Technically Qualified Judge
Technology: Biotechnology
Language: —
First decided: Apr 22, 2025

Decisions

2025-04-22
WithdrawnApplication Rop 265
The Milan Central Division allowed Pfizer's withdrawal of both the revocation action (ACT_45928/2024) and the counterclaim for revocation (CC_60908/2024) against GlaxoSmithKline Biologicals SA concerning EP 4 183 412 (RSV vaccine patent), with GSK's consent and without a cost decision; 60% of court fees were reimbursed to Pfizer.
Legal issues:Withdrawal of revocation action (R. 265 RoP)Court fee reimbursementRSV vaccine patent

Documents